Last 197.00 GBp
Change Today -3.00 / -1.50%
Volume 15.7K
OPTS On Other Exchanges
As of 11:35 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

optos plc (OPTS) Snapshot

200.75 GBp
Previous Close
200.00 GBp
Day High
200.75 GBp
Day Low
195.00 GBp
52 Week High
08/27/14 - 215.00 GBp
52 Week Low
09/12/13 - 146.00 GBp
Market Cap
Average Volume 10 Days
0.10 GBp
Shares Outstanding
Dividend Yield
Current Stock Chart for OPTOS PLC (OPTS)

Related News

No related news articles were found.

optos plc (OPTS) Related Businessweek News

No Related Businessweek News Found

optos plc (OPTS) Details

Optos plc, a retinal imaging company, provides diagnostic and treatment devices to healthcare professionals in North America and internationally. Its medical devices produce ultra-widefield, high resolution digital images of approximately 82% of the retina, which provide clinical information by facilitating the early detection, management, and treatment of disorders and diseases evidenced in the retina, such as retinal detachments and tears, glaucoma, diabetic retinopathy, and age-related macular degeneration. The company’s retinal devices are also used for the treatment of non-eye diseases, including hypertension and cancers. Its ultra-widefield imaging devices include the P200 and 200Dx devices, and the Daytona, which are concentrated on wellness screening carried out in primary care; the P200C devices that are designed to serve the need for clinical imaging capabilities and standards in secondary care within the ophthalmology market and at optometric practices; and the P200MA and 200Tx devices, which support the medical care market. The company also offers optical coherence tomography (OCT) imaging products, such as Optos OCT SLO system, which combines spectral OCT imaging with a confocal scanning ophthalmoscope in an instrument that allows eye care professionals to diagnose and track changes in the retinal diseases and their treatments; Microperimetry that assesses the visual function of a specific area of the retina and fovea, and correlates to the OCT structural changes; and AC Cornea Lens, which provides high-resolution spectral OCT imaging of the cornea and angle. In addition, it provides OCT diagnostic devices and optical ultrasound scanners that are used in the diagnosis and management of eye disease and conditions, as well as develops image management software. The company was founded in 1992 and is headquartered in Dunfermline, the United Kingdom.

435 Employees
Last Reported Date: 01/22/14
Founded in 1992

optos plc (OPTS) Top Compensated Officers

Chief Executive Officer and Executive Directo...
Total Annual Compensation: $518.0K
Compensation as of Fiscal Year 2013.

optos plc (OPTS) Key Developments

Optos plc Announces Unaudited Interim Management Statement for the Third Quarter and Nine Months Ended June 30, 2014

Optos plc announced unaudited interim management statement for the third quarter and nine months ended June 30, 2014. For the quarter, the company headline revenues at $42 million were 5% higher than the comparable period last year driven primarily by growth in new customers and outright sales in direct markets. Net debt has reduced further to $19.5 million at 30 June 2014, $16 million lower than at 30 March 2014 ($35.5 million) and $26.5 million lower than this time last year ($46 million). For the nine months, the company announced underlying revenue grew 13% with headline year-to-date revenues of $114.7 million compared to $113.1 million which were 1.5% above last year.

Optos plc to Report 4 Months 2014 Interim Management Statement on Jul 17, 2014

Optos plc announced that they will report 4 months, 2014 interim management statement on Jul 17, 2014

Optos plc Reports Unaudited Consolidated Earnings Results for the First Half Year Ended March 31, 2014

Optos plc reported unaudited consolidated earnings results for the first half year ended March 31, 2014. For the period, the company reported revenue of $71.9 million compared to $72.2 million a year ago. Operating income was $0.5 million compared to operating loss of $0.6 million a year ago. Profit before taxation was $1.6 million compared to $0.7 million a year ago. Net profit for the period attributable to equity holders of the parent was $1.0 million compared to $0.4 million a year ago. Diluted profit before taxation per ordinary share was 2.2 cents compared to 1.0 cents a year ago. Diluted profit after taxation per ordinary share was 1.3 cents compared to 0.5 cents a year ago. Net cash used in operating activities were $12.8 million compared to $20.1 million a year ago. Purchases of property, plant and equipment was $0.7 million compared to $1.1 million a year ago. Expenditure on intangible assets was $1.9 million compared to $1.0 million a year ago. Net debt as on March 31, 2014 was $35.5 million compared to $55.8 million as of March 31, 2013.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OPTS:LN 197.00 GBp -3.00

OPTS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OPTS.
View Industry Companies

Industry Analysis


Industry Average

Valuation OPTS Industry Range
Price/Earnings 34.7x
Price/Sales 1.5x
Price/Book 1.9x
Price/Cash Flow 33.9x
TEV/Sales 1.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OPTOS PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at